Linsitinib(OSI-906)
产品编号: DC4105
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Linsitinib (OSI-906) 是 IGF-1 和胰岛素受体的双重抑制剂，IC50 分别为35 和 75 nM。
| Cas No.: |
867160-71-2 |
| 名称: |
(1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol |
| 别名: |
OSI 906,OSI906 |
| SMILES: |
CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O |
| 分子式: |
C26H23N5O |
| 分子量: |
421.49 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
Linsitinib (OSI-906): Linsitinib (OSI-906) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. OSI-906 selectively inhibits IGF-1R, which may result in the inhibi |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
| TITLE |
DOWNLOAD |
| MSDS_1350_DC4105_867160-71-2 |
|
COA
| LOT NO. |
DOWNLOAD |
|
|
询盘
